Pivotal regulatory milestone positioning Cellvizio as unique real-time in vivo visualization system Cellvizio platform complementary to a wide range...
Search Results
Mauna Kea Technologies Renews its Equity Financing Facility to Support its Development
Please download the official press release for full details
Mauna Kea Technologies Announces Reimbursement Coverage For Cellvizio® In Croatia
Croatian Health Insurance Fund Now Provides Reimbursement for Cellvizio® advanced endomicroscopy technology for patients affected by...
New Contact Study Analysis Demonstrates Cellvizio’s Ability to Improve The Management of Patients with Pancreatic Cysts
New CONTACT Study Outcomes Presented today in Late-Breaking Session at United European Gastroenterology Week (UEGW) 2017 Mauna Kea Technologies...
Appointment of Olivier Regnard to the position of Deputy Chief Executive Officer and Chief Financial Officer
Mauna Kea Technologies announced the appointment of Olivier Regnard to the position of Deputy Chief Executive Officer and Chief Financial...
New Economic Model Shows Significant Cost Savings when using Cellvizio® to Ascertain Diagnosis of Benign Pancreatic Cysts
Study shows a 23% reduction in surgical interventions resulting in 14% reduction in clinical costs Mauna Kea Technologies today announced the...
Cellvizio® Now CE Marked for Use During Robotic-Assisted Surgery
Mauna Kea Technologies passes another key regulatory milestone on its ambitious product roadmap, positioning Cellvizio as a key technology to...
Mauna Kea Technologies reports H1 financial results
Click to read more
Mauna Kea Technologies Reports First Half 2017 Financial Results
Results reflect strategic focus on transition to Cellvizio pay-per-use business model in the U.S. Mauna Kea Technologies will host a conference call...
Cook Medical Announces Commercial Launch of Cellvizio for Urology
Cook Urology to market private-labeled version of Cellvizio globally Paris and Boston, September 05, 2017 – Mauna Kea Technologies (Euronext:...
Strong Presence of Cellvizio at the OESO 14th World Conference, September 2017
See the complete press release
Mauna Kea Technologies Receives Specific U.S. FDA 510(K) Clearance for use of Cellvizio during Robotic-Assisted Surgery
Robotic-assisted surgery is one of the fastest growing surgical categories worldwide Key milestone in the Cellvizio product development roadmap,...